Plain-English translation of NCT06961968 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , a long-acting injection medication, to see if it can prevent schizophrenia symptoms from flaring up. The study will compare this medication to a placebo (a dummy injection with no active drug) over one year. Researchers want to understand whether this treatment helps keep people's symptoms stable over time.
Many people with schizophrenia have trouble staying on their daily medication, which can lead to their symptoms coming back. A long-acting injection that only needs to be given once a month might help people stay stable more easily, but researchers need to confirm that this treatment actually works.
You likely qualify if…
You likely don't qualify if…
First, you'll spend 12 weeks in a stabilization phase where everyone takes the medication — starting with oral tablets for 6 weeks, then switching to injections for 6 weeks. After that, you'll be randomly assigned to either continue the medication or receive placebo injections for up to one year. You'll receive regular injections at study visits and have your symptoms monitored throughout.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States